Figure 1.

Clinical response and progression-free survival outcomes in 12 patients who were treated with TAEST16001 cells

(A) Waterfall plot of the best clinical response for each evaluable patient.

(B) Swimlane plot shows clinical outcomes of treated patients.

(C) Spider plot shows the change in the sum of the diameters of each patient’s target lesions over time.

(D) Kaplan-Meier estimates of the progression-free survival. Tick marks indicate the time of data censoring at their last date of contact.